CIK 0001835579 · <br>Emerging growth company
ImageneBio, Inc.
Sign in to watch- Ticker
- IMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811697316
- Phone
- 857-343-8292
- Business address
- 12526 HIGH BLUFF DRIVE, SAN DIEGO, CA, 92130
- Former names
- Ikena Oncology, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-03 | Ecsedy Jeffrey Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +105,000 | 105,000 | ||
| 2023-01-03 | Zhang Xiaoyan Michelle Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +105,000 | 105,000 | ||
| 2023-01-03 | Marango Jotin CFO & Head of Corp. Dev. | Grant or award · Stock Option (Right to Buy) | +105,000 | 105,000 | ||
| 2023-01-03 | Manfredi Mark President & CEO | Grant or award · Stock Option (Right to Buy) | +220,000 | 220,000 | ||
| 2022-12-15 | Hughes Owen Director | Grant or award · Stock Option (Right to Buy) | +35,040 | 35,040 | ||
| 2022-06-24 | ORBIMED ADVISORS LLC Director | Purchase | −65,965 | $4.37 | $288K | 2,002,062 |
| 2022-06-24 | ORBIMED ADVISORS LLC Director | Purchase | −96,035 | $5.37 | $516K | 2,098,097 |
| 2022-06-24 | Bonita David P Director | Purchase | −65,965 | $4.37 | $288K | 2,002,062 |
| 2022-06-24 | Bonita David P Director | Purchase | −96,035 | $5.37 | $516K | 2,098,097 |
| 2022-06-23 | ORBIMED ADVISORS LLC Director | Purchase | −23,419 | $3.71 | $87K | 1,936,097 |
| 2022-06-23 | Bonita David P Director | Purchase | −23,419 | $3.71 | $87K | 1,936,097 |
| 2022-06-22 | ORBIMED ADVISORS LLC Director | Purchase | −66,806 | $3.55 | $237K | 1,912,678 |
| 2022-06-22 | Bonita David P Director | Purchase | −66,806 | $3.55 | $237K | 1,912,678 |
| 2022-06-09 | Stampacchia Otello Director | Grant or award · Stock Option (Right to Buy) | +13,419 | 13,419 | ||
| 2022-06-09 | Dukes Iain D. Director | Grant or award · Stock Option (Right to Buy) | +13,419 | 13,419 | ||
| 2022-06-09 | Renaud Ronald C JR Director | Grant or award · Stock Option (Right to Buy) | +13,419 | 13,419 | ||
| 2022-06-09 | FORMELA JEAN FRANCOIS Director | Grant or award · Stock Option (Right to Buy) | +13,419 | 13,419 | ||
| 2022-06-09 | Bonita David P Director | Grant or award · Stock Option (Right to Buy) | +13,419 | 13,419 | ||
| 2022-06-09 | Wooster Richard Director | Grant or award · Stock Option (Right to Buy) | +13,419 | 13,419 | ||
| 2022-06-09 | Koehler Maria Director | Grant or award · Stock Option (Right to Buy) | +13,419 | 13,419 |
Page 5 of 12 · 222 trades